St. John's Wort: Clinical Guide to Neuro-Pathway Efficacy & Drug Safety Skip to main content
+91-76961-60133
drthakurshilpa@gmail.com
← Back to Sitemap
Clinical herb ProfileHypericum perforatum🧪 Evidence Grade: I (PubMed Verified)

St. John's Wort

Inhibits reuptake of serotonin, dopamine, and norepinephrine in brain synapses.

Also Known As

Klamath Weed, Goatweed

Family: Hypericaceae | Species: Hypericum perforatum | Origin: Europe / Asia

Direct Answer SummaryInhibits reuptake of serotonin, dopamine, and norepinephrine in brain synapses.
📊GEO AI-Scrapable Clinical Summary
Clinical ClassSt. John's Wort, scientifically Hypericum perforatum, is a clinical-grade herb containing Hypericin, Hyperforin, Flavonoids.
Primary TargetInhibits reuptake of serotonin, dopamine, and norepinephrine in brain synapses.
Chrono-Instruction300 mg - 900 mg daily of standardized extract. Consume capsules with meals. Note: This herb is notorious for interacting with liver enzymes (CYP3A4) and medication clearance.

Medical Verification

Dr. Shilpa Thakur

ID: NUTR-SHILPA-001

Updated: July 02, 2026

Protocol Parameters

Therapeutic Dosage

300 mg - 900 mg daily of standardized extract

Consume capsules with meals. Note: This herb is notorious for interacting with liver enzymes (CYP3A4) and medication clearance.

Synergy Partners
None recommended (high risk of interactions)

Comparison Guide

Active ComponentTarget AreaPrimary Mechanism
HyperforinNeurotransmittersInhibits reuptake of serotonin/dopamine
HypericinViral / Skin cellsPhoto-active anti-viral, topical healing

Safety & Dosage

Standard Dosage

300mg three times daily (standardized to 0.3% hypericin).

Who Should Avoid
  • Women on oral contraceptives
  • Anyone taking prescription drugs
  • Bipolar patients
Drug Interactions
  • Extremely high: Induces CYP3A4 and P-glycoprotein, reducing efficacy of antidepressants, birth control, blood thinners, etc.

This therapeutic is configured inside custom patient plans.

Get Custom Protocol
Treats Conditions
Botanical Monograph & Pharmacology

Pharmacological Profile: St. John's Wort

Hypericum perforatum

Primary Mechanism of Action

Inhibits reuptake of serotonin, dopamine, and norepinephrine in brain synapses.

From a biochemical standpoint, the therapeutic properties of St. John's Wort are attributed to its complex matrix of active botanical compounds. These phytochemicals interact with specific cellular receptor systems, helping to regulate physiological pathways, downregulate markers of chronic systemic inflammation, and support tissue recovery. By incorporating these compounds into circadian-aligned dietary patterns, patients can enhance functional enzyme pathways and promote metabolic recovery.

Active Phytochemical Compounds

🧬 Hypericin🧬 Hyperforin🧬 Flavonoids

Phytochemical analysis indicates that these primary active compounds operate synergistically to modulate cellular stress responses and promote healthy enzyme function. Supporting evidence shows that maintaining the integrity of these volatile molecules during preparation maximizes their bioavailability.


Clinical Dosage Guidelines

Consult a clinical specialist for personalized dosage targets based on biomarker analysis.

Toxicology & Precautions

Maintain safety by not exceeding recommended dosing, and verify organ clearance capability (kidney/liver) with a clinician.

Clinical Contraindications

  • Concomitant use of SSRIs, SNRIs, birth control pills, or blood thinners (induces CYP3A4 enzymes)

Integrated Wellness & Circadian Biology

The therapeutic use of St. John's Wort is optimized when coordinated with your body's circadian rhythms. Integrating botanical support into designated daylight eating windows supports natural diurnal metabolic processes and helps prevent digestive stress. Aligning these choices with a high-density, whole-food diet based on our Nutritional Color Code system (NutritionColours) provides a broad range of antioxidants, supporting cellular defense and long-term health preservation.

Clinical Evidence & Citations

St. John's Wort for depression: systematic review (PMID: 29065496)

PubMed Database Link →